Comparison between Parabolic Drugs IPO and Standard Chartered PLC IDRS.
Parabolic Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Standard Chartered PLC IDRS is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Parabolic Drugs IPO is up to ₹200.00 Cr whereas the issue size of the Standard Chartered PLC IDRS is up to ₹2,486.35 Cr. The final issue price of Parabolic Drugs IPO is ₹75.00 per share and of Standard Chartered PLC IDRS is ₹104.00 per share.
| Parabolic Drugs IPO | Standard Chartered PLC IDRS | |
|---|---|---|
| Face Value | ₹10 per share | |
| Issue Price (Lower) | ₹75.00 per share | ₹100.00 per share |
| Issue Price (Upper) | ₹85.00 per share | ₹115.00 per share |
| Issue Price (Final) | ₹75.00 per share | ₹104.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 80 shares | 200 shares |
| Fresh Issue Size | 2,46,40,965 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹184.81 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 20,25,702 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹15.19 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,66,66,667 shares | 24,00,00,000 shares |
| Issue Size Total (Amount) | up to ₹200.00 Cr | up to ₹2,486.35 Cr |
Parabolic Drugs IPO opens on Jun 14, 2010, while Standard Chartered PLC IDRS opens on May 25, 2010. The closing date of Parabolic Drugs IPO and Standard Chartered PLC IDRS is Jun 17, 2010, and May 28, 2010, respectively.
| Parabolic Drugs IPO | Standard Chartered PLC IDRS | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 14, 2010 | May 25, 2010 |
| Issue Close | Jun 17, 2010 | May 28, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jul 01, 2010 | Jun 11, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Parabolic Drugs IPO P/E ratio is , as compared to Standard Chartered PLC IDRS P/E ratio of .
| Parabolic Drugs IPO | Standard Chartered PLC IDRS | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.21 | |||||
| Promoter Shareholding (Post-Issue) | 38.04 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹464.19 Cr. | ₹21551.09 Cr. | ||||
| ROE | ||||||
| ROCE | 6.21 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 19.96 | 14.3 |
In the Parabolic Drugs IPO Retail Individual Investors (RII) are offered 91,58,334 shares while in Standard Chartered PLC IDRS retail investors are offered 91,58,334 shares. Qualified Institutional Buyers (QIB) are offered 1,30,83,333 shares in Parabolic Drugs IPO and 8,40,00,000 shares in Standard Chartered PLC IDRS.
| Parabolic Drugs IPO | Standard Chartered PLC IDRS | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 1,30,83,333 shares | 8,40,00,000 shares |
| NII | 39,25,000 shares | 4,32,00,000 shares |
| RII | 91,58,334 shares | 7,20,00,000 shares |
| Employee | 5,00,000 shares | 48,00,000 shares |
| Others | ||
| Total | 2,66,66,667 shares | 20,40,00,000 shares |
Parabolic Drugs IPO subscribed 1.04x in total, whereas Standard Chartered PLC IDRS subscribed 0.00x.
| Parabolic Drugs IPO | Standard Chartered PLC IDRS | |
|---|---|---|
| QIB (times) | 1.48x | 0.00x |
| NII (times) | 1.20x | 0.00x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.40x | 0.00x |
| Employee (times) | 0.11x | 0.00x |
| Other (times) | ||
| Total (times) | 1.04x | 0.00x |
